Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05067127
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:32.510363+00:00
Published At
2025-08-06T00:00:00+00:00
Record Updated At
2026-01-29
Results Posted At
2025-08-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["C3G", "IC-MPGN", "C3 Glomerulopathy", "C3 Glomerulonephritis", "Complement 3 Glomerulopathy", "Complement 3 Glomerulopathy (C3G)", "Complement 3 Glomerulonephritis", "Dense Deposit Disease", "DDD", "Membranoproliferative Glomerulonephritis", "Membranoproliferative Glomerulonephritis (MPGN)", "Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-29"
protocolSection.identificationModule.nctId
"NCT05067127"
protocolSection.identificationModule.officialTitle
"A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-08-06"

Study condition terms

  • C3G (protocolSection.conditionsModule.conditions)
  • IC-MPGN (protocolSection.conditionsModule.conditions)
  • C3 Glomerulopathy (protocolSection.conditionsModule.conditions)
  • C3 Glomerulonephritis (protocolSection.conditionsModule.conditions)
  • Complement 3 Glomerulopathy (protocolSection.conditionsModule.conditions)
  • Complement 3 Glomerulopathy (C3G) (protocolSection.conditionsModule.conditions)
  • Complement 3 Glomerulonephritis (protocolSection.conditionsModule.conditions)
  • Dense Deposit Disease (protocolSection.conditionsModule.conditions)
  • DDD (protocolSection.conditionsModule.conditions)
  • Membranoproliferative Glomerulonephritis (protocolSection.conditionsModule.conditions)
  • Membranoproliferative Glomerulonephritis (MPGN) (protocolSection.conditionsModule.conditions)
  • Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.